AEON Biopharma, Inc. AEON
0.21 USD 0.00 (-1.70%)
At closeNov 4, 2026, 5:57 PM EST
0.22 +0.01 +3.36%
After hours · Nov 4, 5:57 PM ET
0.2086 Day range 0.2267
0.177 52-week range 1.45
- YTD
- -81.04%
- 1 year
- -78.02%
Financial health
Altman Z-Score
-129.35 Distress zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
2 / 9 Weak
Nine pass/fail tests of profitability, leverage and efficiency.
FMP rating
C2 / 5 overall
- DCF 1
- Return on Equity 5
- Return on Assets 1
- Debt / Equity 1
- P/E 1
- P/B 1
Valuation
P/E -0.3×
FY 2019 5y median -0.3× FY 2025
P/S 0.0×
FY 2019 5y median 0.0× FY 2025
P/B -0.2×
FY 2019 5y median -1.2× FY 2025
P/FCF -0.6×
FY 2019 5y median -5.6× FY 2025
EV/EBITDA -2.7×
FY 2019 5y median -5.0× FY 2025
EV/Sales 0.0×
FY 2019 5y median 0.0× FY 2025
FCF Yield -158.6%
FY 2019 5y median -17.9% FY 2025
Profitability
Gross Margin 0.0%
FY 2019 5y median 0.0% FY 2025
Operating Margin 0.0%
FY 2019 5y median 0.0% FY 2025
Net Margin 0.0%
FY 2019 5y median 0.0% FY 2025
ROE 71.3%
FY 2019 5y median 23.7% FY 2025
ROIC 1180.0%
FY 2019 5y median 1180.0% FY 2025
ROA -705.4%
FY 2019 5y median -705.4% FY 2025
Growth (YoY)
Revenue 0.0%
FY 2019 FY 2025
Operating Income -117.5%
FY 2019 FY 2025
EPS (diluted) -105.4%
FY 2019 FY 2025
Free Cash Flow 14.7%
FY 2019 FY 2025
Financial Health
Current Ratio 0.5×
FY 2019 5y median 0.2× FY 2025
Quick Ratio 0.5×
FY 2019 5y median 0.2× FY 2025
Debt / Equity -0.6×
FY 2019 5y median -0.5× FY 2025
Net Debt / EBITDA -2.0×
FY 2019 5y median -2.0× FY 2025
Interest Coverage 0.0×
FY 2019 5y median 0.0× FY 2025
Dividends
Dividend Yield 0.0%
FY 2019 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2019 5y median 0.0% FY 2025
Annual · latest fiscal year ends 2025-12-31